aluates Reports

$ 0.0

Automative

Global Oncology Generic Injectable Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-32O10327

Global and United States Oncology Generic Injectable Drugs Market Report Forecast 2022 2028

BUY CHAPTERS

Global Oncology Generic Injectable Drugs Market Research Report 2025

Code: QYRE-Auto-32O10327

Report

September 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Teva Pharmaceutical

Pfizer Inc

Astrazeneca plc

Roche

Eli Lilly

GlaxoSmithKline PLC

Novartis

Mylan NV

Natco Pharma

Oncology Generic Injectable Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology Generic Injectable Drugs Market

The global market for Oncology Generic Injectable Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Generic drugs are essential in oncology because some anticancer drugs are only available as generics.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Generic Injectable Drugs.

The Oncology Generic Injectable Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Generic Injectable Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Generic Injectable Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oncology Generic Injectable Drugs Market Report

Report Metric	Details
Report Name	Oncology Generic Injectable Drugs Market
CAGR	5%
Segment by Type	Large Molecule Drugs Small Molecule Drugs
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical, Pfizer, AstraZeneca, Roche, Eli Lilly, GlaxoSmithKline, Novartis, Mylan, Natco Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oncology Generic Injectable Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oncology Generic Injectable Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Generic Injectable Drugs Market report?

Ans: The main players in the Oncology Generic Injectable Drugs Market are Teva Pharmaceutical, Pfizer, AstraZeneca, Roche, Eli Lilly, GlaxoSmithKline, Novartis, Mylan, Natco Pharma

What are the Application segmentation covered in the Oncology Generic Injectable Drugs Market report?

Ans: The Applications covered in the Oncology Generic Injectable Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Oncology Generic Injectable Drugs Market report?

Ans: The Types covered in the Oncology Generic Injectable Drugs Market report are Large Molecule Drugs, Small Molecule Drugs

1 Oncology Generic Injectable Drugs Market Overview

1.1 Product Definition

1.2 Oncology Generic Injectable Drugs by Type

1.2.1 Global Oncology Generic Injectable Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Large Molecule Drugs

1.2.3 Small Molecule Drugs

1.3 Oncology Generic Injectable Drugs by Application

1.3.1 Global Oncology Generic Injectable Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Oncology Generic Injectable Drugs Market Size Estimates and Forecasts

1.4.1 Global Oncology Generic Injectable Drugs Revenue 2020-2031

1.4.2 Global Oncology Generic Injectable Drugs Sales 2020-2031

1.4.3 Global Oncology Generic Injectable Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Oncology Generic Injectable Drugs Market Competition by Manufacturers

2.1 Global Oncology Generic Injectable Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Oncology Generic Injectable Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Oncology Generic Injectable Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Oncology Generic Injectable Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oncology Generic Injectable Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oncology Generic Injectable Drugs, Product Type & Application

2.7 Global Key Manufacturers of Oncology Generic Injectable Drugs, Date of Enter into This Industry

2.8 Global Oncology Generic Injectable Drugs Market Competitive Situation and Trends

2.8.1 Global Oncology Generic Injectable Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Oncology Generic Injectable Drugs Players Market Share by Revenue

2.8.3 Global Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oncology Generic Injectable Drugs Market Scenario by Region

3.1 Global Oncology Generic Injectable Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Oncology Generic Injectable Drugs Sales by Region: 2020-2031

3.2.1 Global Oncology Generic Injectable Drugs Sales by Region: 2020-2025

3.2.2 Global Oncology Generic Injectable Drugs Sales by Region: 2026-2031

3.3 Global Oncology Generic Injectable Drugs Revenue by Region: 2020-2031

3.3.1 Global Oncology Generic Injectable Drugs Revenue by Region: 2020-2025

3.3.2 Global Oncology Generic Injectable Drugs Revenue by Region: 2026-2031

3.4 North America Oncology Generic Injectable Drugs Market Facts & Figures by Country

3.4.1 North America Oncology Generic Injectable Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Oncology Generic Injectable Drugs Sales by Country (2020-2031)

3.4.3 North America Oncology Generic Injectable Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Oncology Generic Injectable Drugs Market Facts & Figures by Country

3.5.1 Europe Oncology Generic Injectable Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Oncology Generic Injectable Drugs Sales by Country (2020-2031)

3.5.3 Europe Oncology Generic Injectable Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oncology Generic Injectable Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Oncology Generic Injectable Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Oncology Generic Injectable Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Oncology Generic Injectable Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Oncology Generic Injectable Drugs Market Facts & Figures by Country

3.7.1 Latin America Oncology Generic Injectable Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Oncology Generic Injectable Drugs Sales by Country (2020-2031)

3.7.3 Latin America Oncology Generic Injectable Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oncology Generic Injectable Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Oncology Generic Injectable Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Oncology Generic Injectable Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Oncology Generic Injectable Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Oncology Generic Injectable Drugs Sales by Type (2020-2031)

4.1.1 Global Oncology Generic Injectable Drugs Sales by Type (2020-2025)

4.1.2 Global Oncology Generic Injectable Drugs Sales by Type (2026-2031)

4.1.3 Global Oncology Generic Injectable Drugs Sales Market Share by Type (2020-2031)

4.2 Global Oncology Generic Injectable Drugs Revenue by Type (2020-2031)

4.2.1 Global Oncology Generic Injectable Drugs Revenue by Type (2020-2025)

4.2.2 Global Oncology Generic Injectable Drugs Revenue by Type (2026-2031)

4.2.3 Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Oncology Generic Injectable Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Oncology Generic Injectable Drugs Sales by Application (2020-2031)

5.1.1 Global Oncology Generic Injectable Drugs Sales by Application (2020-2025)

5.1.2 Global Oncology Generic Injectable Drugs Sales by Application (2026-2031)

5.1.3 Global Oncology Generic Injectable Drugs Sales Market Share by Application (2020-2031)

5.2 Global Oncology Generic Injectable Drugs Revenue by Application (2020-2031)

5.2.1 Global Oncology Generic Injectable Drugs Revenue by Application (2020-2025)

5.2.2 Global Oncology Generic Injectable Drugs Revenue by Application (2026-2031)

5.2.3 Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Oncology Generic Injectable Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Teva Pharmaceutical

6.1.1 Teva Pharmaceutical Company Information

6.1.2 Teva Pharmaceutical Description and Business Overview

6.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Product Portfolio

6.1.5 Teva Pharmaceutical Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Oncology Generic Injectable Drugs Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca Oncology Generic Injectable Drugs Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Roche

6.4.1 Roche Company Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Roche Oncology Generic Injectable Drugs Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 Eli Lilly

6.5.1 Eli Lilly Company Information

6.5.2 Eli Lilly Description and Business Overview

6.5.3 Eli Lilly Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Eli Lilly Oncology Generic Injectable Drugs Product Portfolio

6.5.5 Eli Lilly Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Company Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Novartis

6.7.1 Novartis Company Information

6.7.2 Novartis Description and Business Overview

6.7.3 Novartis Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Novartis Oncology Generic Injectable Drugs Product Portfolio

6.7.5 Novartis Recent Developments/Updates

6.8 Mylan

6.8.1 Mylan Company Information

6.8.2 Mylan Description and Business Overview

6.8.3 Mylan Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Mylan Oncology Generic Injectable Drugs Product Portfolio

6.8.5 Mylan Recent Developments/Updates

6.9 Natco Pharma

6.9.1 Natco Pharma Company Information

6.9.2 Natco Pharma Description and Business Overview

6.9.3 Natco Pharma Oncology Generic Injectable Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Natco Pharma Oncology Generic Injectable Drugs Product Portfolio

6.9.5 Natco Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oncology Generic Injectable Drugs Industry Chain Analysis

7.2 Oncology Generic Injectable Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oncology Generic Injectable Drugs Production Mode & Process Analysis

7.4 Oncology Generic Injectable Drugs Sales and Marketing

7.4.1 Oncology Generic Injectable Drugs Sales Channels

7.4.2 Oncology Generic Injectable Drugs Distributors

7.5 Oncology Generic Injectable Drugs Customer Analysis

8 Oncology Generic Injectable Drugs Market Dynamics

8.1 Oncology Generic Injectable Drugs Industry Trends

8.2 Oncology Generic Injectable Drugs Market Drivers

8.3 Oncology Generic Injectable Drugs Market Challenges

8.4 Oncology Generic Injectable Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical

Pfizer Inc

Astrazeneca plc

Roche

Eli Lilly

GlaxoSmithKline PLC

Novartis

Mylan NV

Natco Pharma

List of Tables

Table 1. Global Oncology Generic Injectable Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Oncology Generic Injectable Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Oncology Generic Injectable Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Oncology Generic Injectable Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Oncology Generic Injectable Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Oncology Generic Injectable Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Oncology Generic Injectable Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Oncology Generic Injectable Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Oncology Generic Injectable Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oncology Generic Injectable Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oncology Generic Injectable Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Oncology Generic Injectable Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oncology Generic Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Generic Injectable Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oncology Generic Injectable Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Oncology Generic Injectable Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Oncology Generic Injectable Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Oncology Generic Injectable Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Oncology Generic Injectable Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Oncology Generic Injectable Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Oncology Generic Injectable Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Oncology Generic Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Oncology Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Oncology Generic Injectable Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Oncology Generic Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Oncology Generic Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Oncology Generic Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Oncology Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Oncology Generic Injectable Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Oncology Generic Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Oncology Generic Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Oncology Generic Injectable Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Oncology Generic Injectable Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Oncology Generic Injectable Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Oncology Generic Injectable Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Oncology Generic Injectable Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oncology Generic Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Oncology Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Oncology Generic Injectable Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Oncology Generic Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oncology Generic Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Oncology Generic Injectable Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Oncology Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Oncology Generic Injectable Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Oncology Generic Injectable Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Oncology Generic Injectable Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Oncology Generic Injectable Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Oncology Generic Injectable Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Oncology Generic Injectable Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Oncology Generic Injectable Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Oncology Generic Injectable Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Oncology Generic Injectable Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Oncology Generic Injectable Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Oncology Generic Injectable Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Oncology Generic Injectable Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Oncology Generic Injectable Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Oncology Generic Injectable Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Oncology Generic Injectable Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Oncology Generic Injectable Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Oncology Generic Injectable Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Oncology Generic Injectable Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Oncology Generic Injectable Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Teva Pharmaceutical Company Information

Table 71. Teva Pharmaceutical Description and Business Overview

Table 72. Teva Pharmaceutical Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Teva Pharmaceutical Oncology Generic Injectable Drugs Product

Table 74. Teva Pharmaceutical Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Oncology Generic Injectable Drugs Product

Table 79. Pfizer Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. AstraZeneca Oncology Generic Injectable Drugs Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Roche Company Information

Table 86. Roche Description and Business Overview

Table 87. Roche Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Roche Oncology Generic Injectable Drugs Product

Table 89. Roche Recent Developments/Updates

Table 90. Eli Lilly Company Information

Table 91. Eli Lilly Description and Business Overview

Table 92. Eli Lilly Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Eli Lilly Oncology Generic Injectable Drugs Product

Table 94. Eli Lilly Recent Developments/Updates

Table 95. GlaxoSmithKline Company Information

Table 96. GlaxoSmithKline Description and Business Overview

Table 97. GlaxoSmithKline Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline Oncology Generic Injectable Drugs Product

Table 99. GlaxoSmithKline Recent Developments/Updates

Table 100. Novartis Company Information

Table 101. Novartis Description and Business Overview

Table 102. Novartis Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Novartis Oncology Generic Injectable Drugs Product

Table 104. Novartis Recent Developments/Updates

Table 105. Mylan Company Information

Table 106. Mylan Description and Business Overview

Table 107. Mylan Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Mylan Oncology Generic Injectable Drugs Product

Table 109. Mylan Recent Developments/Updates

Table 110. Natco Pharma Company Information

Table 111. Natco Pharma Description and Business Overview

Table 112. Natco Pharma Oncology Generic Injectable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Natco Pharma Oncology Generic Injectable Drugs Product

Table 114. Natco Pharma Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Oncology Generic Injectable Drugs Distributors List

Table 118. Oncology Generic Injectable Drugs Customers List

Table 119. Oncology Generic Injectable Drugs Market Trends

Table 120. Oncology Generic Injectable Drugs Market Drivers

Table 121. Oncology Generic Injectable Drugs Market Challenges

Table 122. Oncology Generic Injectable Drugs Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oncology Generic Injectable Drugs

Figure 2. Global Oncology Generic Injectable Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oncology Generic Injectable Drugs Market Share by Type: 2024 & 2031

Figure 4. Large Molecule Drugs Product Picture

Figure 5. Small Molecule Drugs Product Picture

Figure 6. Global Oncology Generic Injectable Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Oncology Generic Injectable Drugs Market Share by Application: 2024 & 2031

Figure 8. Hospital Pharmacies

Figure 9. Retail Pharmacies

Figure 10. Online Pharmacies

Figure 11. Global Oncology Generic Injectable Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Oncology Generic Injectable Drugs Market Size (2020-2031) & (US$ Million)

Figure 13. Global Oncology Generic Injectable Drugs Sales (2020-2031) & (K Units)

Figure 14. Global Oncology Generic Injectable Drugs Average Price (USD/Unit) & (2020-2031)

Figure 15. Oncology Generic Injectable Drugs Report Years Considered

Figure 16. Oncology Generic Injectable Drugs Sales Share by Manufacturers in 2024

Figure 17. Global Oncology Generic Injectable Drugs Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Oncology Generic Injectable Drugs Players: Market Share by Revenue in Oncology Generic Injectable Drugs in 2024

Figure 19. Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Oncology Generic Injectable Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Oncology Generic Injectable Drugs Sales Market Share by Country (2020-2031)

Figure 22. North America Oncology Generic Injectable Drugs Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Oncology Generic Injectable Drugs Sales Market Share by Country (2020-2031)

Figure 26. Europe Oncology Generic Injectable Drugs Revenue Market Share by Country (2020-2031)

Figure 27. Germany Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Oncology Generic Injectable Drugs Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Oncology Generic Injectable Drugs Revenue Market Share by Region (2020-2031)

Figure 34. China Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Oncology Generic Injectable Drugs Sales Market Share by Country (2020-2031)

Figure 45. Latin America Oncology Generic Injectable Drugs Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Oncology Generic Injectable Drugs Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Oncology Generic Injectable Drugs Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Oncology Generic Injectable Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Oncology Generic Injectable Drugs by Type (2020-2031)

Figure 55. Global Revenue Market Share of Oncology Generic Injectable Drugs by Type (2020-2031)

Figure 56. Global Oncology Generic Injectable Drugs Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Oncology Generic Injectable Drugs by Application (2020-2031)

Figure 58. Global Revenue Market Share of Oncology Generic Injectable Drugs by Application (2020-2031)

Figure 59. Global Oncology Generic Injectable Drugs Price (USD/Unit) by Application (2020-2031)

Figure 60. Oncology Generic Injectable Drugs Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Generic Oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology and Cancer Treatment Drug Market Research Report 2024

Cancer Generics Market

Generic Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Breast Cancer Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Drugs for Multiple Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Personalized Medicines In Oncology Market Research Report 2024

Global Generic Injectables for Infectious Diseases Market Research Report 2024

Global Anticancer Injection Market Research Report 2024

Generic Oncology Sterile Injectable Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Injection Drug Market Research Report 2025

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Large Molecule Injectable Drugs Market Research Report 2024

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibodies in Oncology Market Research Report 2024

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intratumoral Cancer Therapies Market Research Report 2025

Global Generic Injectable Drugs Market Research Report 2024

Global Personalized Medicine for Cancer Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions